医薬品中間体市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00005559
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 185
Buy Now

医薬品中間体市場は、2020 年の 273 億 5,670 万米ドルから、2028 年には 372 億 9,033 万米ドルに達すると予想されています。市場は、2021 年から 2028 年にかけて 4.2% の CAGR で成長すると推定されています。



医薬品中間体市場は、種類、用途、流通チャネル、地域に基づいて分析されています。地域に基づく市場は、北米、ヨーロッパ、アジア太平洋、中東およびアフリカ、南米および中央アメリカに分割されています。レポートは、市場動向、技術の進歩、市場力学、大手企業の競争状況分析などのパラメーターに重点を置き、医薬品中間体市場の洞察と詳細な分析を提供します。また、すべての主要地域の市場全体における新型コロナウイルス感染症のパンデミックの分析も含まれています。



医薬品中間体市場にとって有利な地域



市場洞察



慢性疾患および感染症の有病率の上昇



< p>医薬品中間体は、医薬品有効成分 (API) の構成要素です。これらは、原薬の製造中に分子変化または加工を受ける原材料です。したがって、慢性疾患を治療するための薬剤の需要の増加に伴い、医薬中間体の必要性も増加しています。疾病管理予防センター (CDC) によると、米国の成人 10 人に 6 人が、がん、心臓病、肺疾患、脳卒中、神経疾患、糖尿病、腎臓病などの少なくとも 1 つの慢性疾患を患っています。さらに、この国の成人10人に4人は2つ以上の慢性疾患を抱えています。さらに、欧州慢性疾患同盟(ECDA)のプレスリリースによると、2014年にはヨーロッパの10人中9人が慢性疾患が原因で死亡しています。したがって、総医療費の 70 ~ 80% が慢性疾患の管理に費やされています。



特に東南アジアにおける感染症の蔓延の急増も、今後数年間で API の需要を促進し、最終的には医薬品中間市場の成長を促進すると考えられます。たとえば、改訂された国家結核対策計画報告書によると、2018年にインドでは約44万人の患者が結核で死亡しており、これは世界中で結核による死亡者数合計150万人の29%に相当します。したがって、慢性疾患や感染症のこのような高い有病率は医薬品の需要を高めており、最終的には医薬品中間体の必要性を浮き彫りにしています。



タイプベースの洞察



医薬品中間体市場、タイプは、GMP と非 GMP に分類されます。 GMP セグメントは 2020 年に市場で最大のシェアを保持しましたが、同じセグメントは予測期間中に市場で 4.4% という最高の CAGR を記録すると予想されます。




医薬品中間体市場、タイプ別 - 2020 年と 2028 年



アプリケーションベースの洞察



医薬中間体市場は、アプリケーション別に、抗生物質、解熱鎮痛剤、ビタミン、その他。抗生物質セグメントは2020年に市場で最大のシェアを占め、また、このセグメントは予測期間中に市場で最高のCAGR 4.9%を記録すると予想されています。




流通チャネルベースの洞察



流通チャネルに基づいて、医薬品中間体市場は流通業者と直接販売に分類されています。 2020 年には直販部門が市場で最大のシェアを占め、販売代理店部門は予測期間中に市場で 4.2% という最高の CAGR を記録すると推定されています。



戦略的洞察



医薬品中間体市場で事業を展開している企業は、世界中で自社の拠点と製品ポートフォリオを拡大し、増大する需要に対応するために、製品の発売や拡張などの有機的な戦略を採用しています。



タイプ別



  • GMP

  • 非GMP


用途別





  • 抗生物質

  • 解熱鎮痛薬
  • ビタミン

  • その他


流通チャネル別





  • 販売業者

  • 直接販売

地理別





  • 北米

    • 米国

    • カナダ

    • メキシコ



  • ヨーロッパ

    • ドイツ

    • フランス

    • イタリア

    • イギリス

    • スペイン

    • スイス

    • ベルギー

    • ギリシャ

    • ノルウェー

    • ポルトガル

    • スウェーデン

    • チェコ共和国

    • クロアチア

    • アイルランド

    • デンマーク

    • オランダ

    • ロシア< /li>
    • その他のヨーロッパ



  • アジア太平洋 (APAC)

    • 中国

    • インド

    • 韓国

    • 日本

    • オーストラリア

    • アジア太平洋地域のその他の地域



  • 中東およびアフリカ (MEA) )

    • 南アフリカ

    • サウジアラビア

    • アラブ首長国連邦

    • トルコ

    • MEAの残りの部分


    • 中南米 (SCAM)

      • ブラジル

      • アルゼンチン

      • その他の SCAM


      < /li>

    会社概要





    • ファイザー株式会社

    • ディッシュマン グループ

    • デエクストラ ラボラトリーズ リミテッド

    • Sanofi Winthrop Industries SA

    • Vertellus Holdings LLC

    • BASF SE

    • Lianhetech

    • Codexis

    • Midas Pharma GmbH

    • Chiracon GmbH


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the Pharmaceutical Intermediates market across the globe?

Key factors that are driving the market are to rising prevalence of chronic diseases and infectious diseases, and escalating investment by pharmaceutical companies in R&D activities. However, high cost of drug manufacturing hinders the market growth.

What are Pharmaceutical Intermediates?

Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. Pharmaceutical intermediates are used in the production of bulk drugs as well as for research and development purpose by various pharm and biopharma companies. Pharmaceutical intermediates are formed at the time of process of production or synthesis of active pharmaceutical ingredients.

What is the cost of Pharmaceutical Intermediates?

The costs of the Pharmaceutical Intermediates are much higher, and they may cost US$ 5–50, or more, per kgs. The cost may also differ from product to product types.

The List of Companies - Pharmaceutical Intermediate Market

  1. Pfizer Inc.
  2. Sanofi
  3. BASF SE
  4. Lianhe Chemical Technology Co., Ltd
  5. Dishman Carbogen Amcis Ltd
  6. Codexis
  7. Midas Pharma GmbH
  8. chiracon GmbH
  9. Dextra Laboratories Limited
  10. Vertellus Holdings LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports